Cancer stem cells in hepatocellular carcinoma — from origin to clinical implicationsTerence K. Lee, Stephanie Ma|Nature Reviews Gastroenterology & Hepatology|2021Cited by 472
EPHB2 Activates β-Catenin to Enhance Cancer Stem Cell Properties and Drive Sorafenib Resistance in Hepatocellular CarcinomaHoi-Wing Leung, Terence K. Lee|Cancer Research|2021Cited by 130
Caspase-3–Induced Activation of SREBP2 Drives Drug Resistance via Promotion of Cholesterol Biosynthesis in Hepatocellular CarcinomaEtienne Ho Kit Mok, Terence K. Lee, Kin Sum Leung et al.|Cancer Research|2022Cited by 106
FTY720 induces apoptosis of human hepatoma cell lines through PI3-K-mediated Akt dephosphorylationTerence K. Lee, Sheung Tat Fan|Carcinogenesis|2004Cited by 79
NRF2/SHH signaling cascade promotes tumor-initiating cell lineage and drug resistance in hepatocellular carcinomaHoi-Wing Leung, Terence K. Lee, Eunice Y. Lau et al.|Cancer Letters|2020Cited by 53